Page last updated: 2024-11-03

propranolol and Sarcoma 37

propranolol has been researched along with Sarcoma 37 in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Sarcoma 37: An experimental sarcoma of mice.

Research Excerpts

ExcerptRelevanceReference
"The sites of specific binding of 3H-L-dihydroalprenolol (3H-DHA) were identified on the surface of ascites sarcoma 37 cells, using competitive displacement and binding of the beta-adrenergic antagonists, 3H-DHA and L-propranolol."3.67[Interaction of sarcolysine with beta-adrenoreceptors in tumor cells]. ( Belousova, AK; Khabarov, SV; Solntseva, TI, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belousova, AK1
Solntseva, TI1
Khabarov, SV1

Other Studies

1 other study available for propranolol and Sarcoma 37

ArticleYear
[Interaction of sarcolysine with beta-adrenoreceptors in tumor cells].
    Biokhimiia (Moscow, Russia), 1985, Volume: 50, Issue:11

    Topics: Adenylyl Cyclases; Animals; Binding Sites; Binding, Competitive; Dihydroalprenolol; In Vitro Techniq

1985